{"id":"W4239531242","doi":"10.2165/00128413-200414290-00064","title":"The Therapeutic Products Directorate of Health Canada has approved gemifloxacin","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Gemifloxacin; Medicine; Pharmacy; Environmental health; Family medicine; Moxifloxacin; Microbiology; Antibiotics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0112668,0.0001972142,0.000819628,0.0001005147,0.0004741017,0.00008241181,0.0004289999,0.00005770151,0.00005279894],"category_scores_gemma":[0.001103723,0.000193575,0.00006902656,0.0003069881,0.0001344228,0.0002214138,0.00004330976,0.0001997349,0.0002040213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001157162,"about_ca_system_score_gemma":0.002857465,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.424143,"about_ca_topic_score_gemma":0.1550162,"domain_scores_codex":[0.9951388,0.0003551455,0.003378758,0.0004522729,0.0001423623,0.0005327095],"domain_scores_gemma":[0.9962018,0.0004760353,0.002430217,0.0006291762,0.000114163,0.000148681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001693136,0.0007658112,0.03063831,0.002987363,0.001021796,0.000007518165,0.01273908,0.005083398,0.0006498311,0.2523075,0.6790197,0.01461034],"study_design_scores_gemma":[0.001939112,0.000137546,0.03021706,0.0001044073,0.00000918101,0.000007466552,0.001261613,0.0007201102,0.0007590903,0.01540892,0.9489218,0.0005136715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2529716,0.02615197,0.00142968,0.7121821,0.002745358,0.00183257,0.0003762354,0.00008796182,0.002222497],"genre_scores_gemma":[0.9831215,0.0002585631,0.0004435951,0.01516136,0.0002554436,0.00008773315,0.00001876813,0.00003768456,0.0006153422],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7301499,"threshold_uncertainty_score":0.8604026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3939423323082523,"score_gpt":0.4025350128563726,"score_spread":0.008592680548120346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}